nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.139	0.192	CbGbCtD
Lercanidipine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0922	0.128	CbGbCtD
Lercanidipine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0922	0.128	CbGbCtD
Lercanidipine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0713	0.0987	CbGbCtD
Lercanidipine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0692	0.0958	CbGbCtD
Lercanidipine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0541	0.0748	CbGbCtD
Lercanidipine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0464	0.0642	CbGbCtD
Lercanidipine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0458	0.0633	CbGbCtD
Lercanidipine—CYP3A4—Prednisone—ankylosing spondylitis	0.0432	0.0598	CbGbCtD
Lercanidipine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0424	0.0587	CbGbCtD
Lercanidipine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.027	0.0373	CbGbCtD
Lercanidipine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000564	0.00203	CcSEcCtD
Lercanidipine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000562	0.00202	CcSEcCtD
Lercanidipine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000562	0.00202	CcSEcCtD
Lercanidipine—Eye disorder—Prednisone—ankylosing spondylitis	0.000561	0.00202	CcSEcCtD
Lercanidipine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00056	0.00202	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000558	0.00201	CcSEcCtD
Lercanidipine—Flushing—Prednisone—ankylosing spondylitis	0.000558	0.00201	CcSEcCtD
Lercanidipine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000557	0.00201	CcSEcCtD
Lercanidipine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000557	0.00201	CcSEcCtD
Lercanidipine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000557	0.002	CcSEcCtD
Lercanidipine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000556	0.002	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000555	0.002	CcSEcCtD
Lercanidipine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000551	0.00198	CcSEcCtD
Lercanidipine—Renal failure—Methotrexate—ankylosing spondylitis	0.00055	0.00198	CcSEcCtD
Lercanidipine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000549	0.00198	CcSEcCtD
Lercanidipine—Angioedema—Betamethasone—ankylosing spondylitis	0.000549	0.00198	CcSEcCtD
Lercanidipine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000545	0.00196	CcSEcCtD
Lercanidipine—Angiopathy—Prednisone—ankylosing spondylitis	0.000545	0.00196	CcSEcCtD
Lercanidipine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000543	0.00196	CcSEcCtD
Lercanidipine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000543	0.00195	CcSEcCtD
Lercanidipine—Malaise—Dexamethasone—ankylosing spondylitis	0.000542	0.00195	CcSEcCtD
Lercanidipine—Malaise—Betamethasone—ankylosing spondylitis	0.000542	0.00195	CcSEcCtD
Lercanidipine—Vertigo—Betamethasone—ankylosing spondylitis	0.00054	0.00194	CcSEcCtD
Lercanidipine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00054	0.00194	CcSEcCtD
Lercanidipine—Syncope—Dexamethasone—ankylosing spondylitis	0.000539	0.00194	CcSEcCtD
Lercanidipine—Syncope—Betamethasone—ankylosing spondylitis	0.000539	0.00194	CcSEcCtD
Lercanidipine—Shock—Triamcinolone—ankylosing spondylitis	0.000531	0.00191	CcSEcCtD
Lercanidipine—Insomnia—Prednisolone—ankylosing spondylitis	0.000531	0.00191	CcSEcCtD
Lercanidipine—Alopecia—Prednisone—ankylosing spondylitis	0.000531	0.00191	CcSEcCtD
Lercanidipine—Shock—Methylprednisolone—ankylosing spondylitis	0.00053	0.00191	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000529	0.0019	CcSEcCtD
Lercanidipine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000529	0.0019	CcSEcCtD
Lercanidipine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000528	0.0019	CcSEcCtD
Lercanidipine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000528	0.0019	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000527	0.0019	CcSEcCtD
Lercanidipine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000527	0.0019	CcSEcCtD
Lercanidipine—Mental disorder—Prednisone—ankylosing spondylitis	0.000526	0.0019	CcSEcCtD
Lercanidipine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000526	0.00189	CcSEcCtD
Lercanidipine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000524	0.00189	CcSEcCtD
Lercanidipine—Erythema—Prednisone—ankylosing spondylitis	0.000523	0.00188	CcSEcCtD
Lercanidipine—Malnutrition—Prednisone—ankylosing spondylitis	0.000523	0.00188	CcSEcCtD
Lercanidipine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000522	0.00188	CcSEcCtD
Lercanidipine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000522	0.00188	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000521	0.00188	CcSEcCtD
Lercanidipine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000511	0.00184	CcSEcCtD
Lercanidipine—Myalgia—Betamethasone—ankylosing spondylitis	0.000511	0.00184	CcSEcCtD
Lercanidipine—Anxiety—Betamethasone—ankylosing spondylitis	0.00051	0.00183	CcSEcCtD
Lercanidipine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00051	0.00183	CcSEcCtD
Lercanidipine—Discomfort—Betamethasone—ankylosing spondylitis	0.000505	0.00182	CcSEcCtD
Lercanidipine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000505	0.00182	CcSEcCtD
Lercanidipine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000504	0.00181	CcSEcCtD
Lercanidipine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000502	0.00181	CcSEcCtD
Lercanidipine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000496	0.00179	CcSEcCtD
Lercanidipine—Vision blurred—Prednisone—ankylosing spondylitis	0.000493	0.00177	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000492	0.00177	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000492	0.00177	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000491	0.00177	CcSEcCtD
Lercanidipine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000489	0.00176	CcSEcCtD
Lercanidipine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000487	0.00176	CcSEcCtD
Lercanidipine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000485	0.00175	CcSEcCtD
Lercanidipine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000485	0.00175	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000484	0.00174	CcSEcCtD
Lercanidipine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000484	0.00174	CcSEcCtD
Lercanidipine—Anaemia—Prednisone—ankylosing spondylitis	0.000483	0.00174	CcSEcCtD
Lercanidipine—Shock—Dexamethasone—ankylosing spondylitis	0.000482	0.00174	CcSEcCtD
Lercanidipine—Shock—Betamethasone—ankylosing spondylitis	0.000482	0.00174	CcSEcCtD
Lercanidipine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000482	0.00173	CcSEcCtD
Lercanidipine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000481	0.00173	CcSEcCtD
Lercanidipine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000481	0.00173	CcSEcCtD
Lercanidipine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00048	0.00173	CcSEcCtD
Lercanidipine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00048	0.00173	CcSEcCtD
Lercanidipine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000478	0.00172	CcSEcCtD
Lercanidipine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000478	0.00172	CcSEcCtD
Lercanidipine—Angioedema—Prednisone—ankylosing spondylitis	0.000478	0.00172	CcSEcCtD
Lercanidipine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000476	0.00171	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000475	0.00171	CcSEcCtD
Lercanidipine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000474	0.00171	CcSEcCtD
Lercanidipine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000474	0.00171	CcSEcCtD
Lercanidipine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000474	0.00171	CcSEcCtD
Lercanidipine—Malaise—Prednisone—ankylosing spondylitis	0.000472	0.0017	CcSEcCtD
Lercanidipine—Vertigo—Prednisone—ankylosing spondylitis	0.00047	0.00169	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000469	0.00169	CcSEcCtD
Lercanidipine—Syncope—Prednisone—ankylosing spondylitis	0.000469	0.00169	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000468	0.00169	CcSEcCtD
Lercanidipine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000467	0.00168	CcSEcCtD
Lercanidipine—Anorexia—Betamethasone—ankylosing spondylitis	0.000467	0.00168	CcSEcCtD
Lercanidipine—Urticaria—Prednisolone—ankylosing spondylitis	0.000467	0.00168	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000466	0.00168	CcSEcCtD
Lercanidipine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000466	0.00168	CcSEcCtD
Lercanidipine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000465	0.00167	CcSEcCtD
Lercanidipine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00046	0.00166	CcSEcCtD
Lercanidipine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000458	0.00165	CcSEcCtD
Lercanidipine—Hypotension—Betamethasone—ankylosing spondylitis	0.000458	0.00165	CcSEcCtD
Lercanidipine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000456	0.00164	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000454	0.00163	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000453	0.00163	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000447	0.00161	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000447	0.00161	CcSEcCtD
Lercanidipine—Arthralgia—Prednisone—ankylosing spondylitis	0.000445	0.0016	CcSEcCtD
Lercanidipine—Myalgia—Prednisone—ankylosing spondylitis	0.000445	0.0016	CcSEcCtD
Lercanidipine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000445	0.0016	CcSEcCtD
Lercanidipine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000444	0.0016	CcSEcCtD
Lercanidipine—Anxiety—Prednisone—ankylosing spondylitis	0.000444	0.0016	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—ankylosing spondylitis	0.000444	0.0016	CcSEcCtD
Lercanidipine—Insomnia—Betamethasone—ankylosing spondylitis	0.000443	0.0016	CcSEcCtD
Lercanidipine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000443	0.0016	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000442	0.00159	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000441	0.00159	CcSEcCtD
Lercanidipine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00044	0.00158	CcSEcCtD
Lercanidipine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00044	0.00158	CcSEcCtD
Lercanidipine—Discomfort—Prednisone—ankylosing spondylitis	0.00044	0.00158	CcSEcCtD
Lercanidipine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00044	0.00158	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—ankylosing spondylitis	0.000437	0.00157	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000437	0.00157	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000433	0.00156	CcSEcCtD
Lercanidipine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000431	0.00155	CcSEcCtD
Lercanidipine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000431	0.00155	CcSEcCtD
Lercanidipine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000429	0.00155	CcSEcCtD
Lercanidipine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000428	0.00154	CcSEcCtD
Lercanidipine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000428	0.00154	CcSEcCtD
Lercanidipine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000427	0.00154	CcSEcCtD
Lercanidipine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000426	0.00153	CcSEcCtD
Lercanidipine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000426	0.00153	CcSEcCtD
Lercanidipine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000426	0.00153	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000423	0.00152	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000423	0.00152	CcSEcCtD
Lercanidipine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000423	0.00152	CcSEcCtD
Lercanidipine—Fatigue—Betamethasone—ankylosing spondylitis	0.000423	0.00152	CcSEcCtD
Lercanidipine—Shock—Prednisone—ankylosing spondylitis	0.00042	0.00151	CcSEcCtD
Lercanidipine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000419	0.00151	CcSEcCtD
Lercanidipine—Tachycardia—Prednisone—ankylosing spondylitis	0.000417	0.0015	CcSEcCtD
Lercanidipine—Skin disorder—Prednisone—ankylosing spondylitis	0.000415	0.00149	CcSEcCtD
Lercanidipine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000413	0.00149	CcSEcCtD
Lercanidipine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000412	0.00148	CcSEcCtD
Lercanidipine—Anorexia—Prednisone—ankylosing spondylitis	0.000407	0.00147	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000406	0.00146	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—ankylosing spondylitis	0.000404	0.00145	CcSEcCtD
Lercanidipine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000404	0.00145	CcSEcCtD
Lercanidipine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000404	0.00145	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000401	0.00144	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000401	0.00144	CcSEcCtD
Lercanidipine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000398	0.00143	CcSEcCtD
Lercanidipine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000397	0.00143	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—ankylosing spondylitis	0.000394	0.00142	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—ankylosing spondylitis	0.000393	0.00141	CcSEcCtD
Lercanidipine—Urticaria—Betamethasone—ankylosing spondylitis	0.000389	0.0014	CcSEcCtD
Lercanidipine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000389	0.0014	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000389	0.0014	CcSEcCtD
Lercanidipine—Dizziness—Prednisolone—ankylosing spondylitis	0.000388	0.0014	CcSEcCtD
Lercanidipine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000388	0.0014	CcSEcCtD
Lercanidipine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000387	0.0014	CcSEcCtD
Lercanidipine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000387	0.0014	CcSEcCtD
Lercanidipine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000387	0.0014	CcSEcCtD
Lercanidipine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000387	0.0014	CcSEcCtD
Lercanidipine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000387	0.00139	CcSEcCtD
Lercanidipine—Insomnia—Prednisone—ankylosing spondylitis	0.000386	0.00139	CcSEcCtD
Lercanidipine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000383	0.00138	CcSEcCtD
Lercanidipine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000382	0.00138	CcSEcCtD
Lercanidipine—Cough—Methotrexate—ankylosing spondylitis	0.000381	0.00137	CcSEcCtD
Lercanidipine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000381	0.00137	CcSEcCtD
Lercanidipine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000376	0.00135	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—ankylosing spondylitis	0.000372	0.00134	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000372	0.00134	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—ankylosing spondylitis	0.000372	0.00134	CcSEcCtD
Lercanidipine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000371	0.00134	CcSEcCtD
Lercanidipine—Rash—Prednisolone—ankylosing spondylitis	0.00037	0.00133	CcSEcCtD
Lercanidipine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00037	0.00133	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00037	0.00133	CcSEcCtD
Lercanidipine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000369	0.00133	CcSEcCtD
Lercanidipine—Fatigue—Prednisone—ankylosing spondylitis	0.000368	0.00133	CcSEcCtD
Lercanidipine—Headache—Prednisolone—ankylosing spondylitis	0.000368	0.00133	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—ankylosing spondylitis	0.000368	0.00132	CcSEcCtD
Lercanidipine—Constipation—Prednisone—ankylosing spondylitis	0.000365	0.00131	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—ankylosing spondylitis	0.00036	0.0013	CcSEcCtD
Lercanidipine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000357	0.00129	CcSEcCtD
Lercanidipine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000356	0.00128	CcSEcCtD
Lercanidipine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000352	0.00127	CcSEcCtD
Lercanidipine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000352	0.00127	CcSEcCtD
Lercanidipine—Asthenia—Betamethasone—ankylosing spondylitis	0.000352	0.00127	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00035	0.00126	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000349	0.00126	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000349	0.00126	CcSEcCtD
Lercanidipine—Nausea—Prednisolone—ankylosing spondylitis	0.000349	0.00126	CcSEcCtD
Lercanidipine—Pruritus—Betamethasone—ankylosing spondylitis	0.000347	0.00125	CcSEcCtD
Lercanidipine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000347	0.00125	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000347	0.00125	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000345	0.00124	CcSEcCtD
Lercanidipine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000343	0.00124	CcSEcCtD
Lercanidipine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000343	0.00123	CcSEcCtD
Lercanidipine—Rash—Triamcinolone—ankylosing spondylitis	0.000341	0.00123	CcSEcCtD
Lercanidipine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00034	0.00123	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—ankylosing spondylitis	0.00034	0.00122	CcSEcCtD
Lercanidipine—Rash—Methylprednisolone—ankylosing spondylitis	0.00034	0.00122	CcSEcCtD
Lercanidipine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00034	0.00122	CcSEcCtD
Lercanidipine—Urticaria—Prednisone—ankylosing spondylitis	0.000339	0.00122	CcSEcCtD
Lercanidipine—Headache—Triamcinolone—ankylosing spondylitis	0.000338	0.00122	CcSEcCtD
Lercanidipine—Headache—Methylprednisolone—ankylosing spondylitis	0.000338	0.00122	CcSEcCtD
Lercanidipine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000337	0.00122	CcSEcCtD
Lercanidipine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000337	0.00122	CcSEcCtD
Lercanidipine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000335	0.00121	CcSEcCtD
Lercanidipine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000335	0.00121	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—ankylosing spondylitis	0.000333	0.0012	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000325	0.00117	CcSEcCtD
Lercanidipine—Dizziness—Betamethasone—ankylosing spondylitis	0.000324	0.00117	CcSEcCtD
Lercanidipine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000324	0.00117	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—ankylosing spondylitis	0.000323	0.00116	CcSEcCtD
Lercanidipine—Nausea—Triamcinolone—ankylosing spondylitis	0.000321	0.00116	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00032	0.00115	CcSEcCtD
Lercanidipine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00032	0.00115	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000318	0.00115	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—ankylosing spondylitis	0.000317	0.00114	CcSEcCtD
Lercanidipine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000314	0.00113	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000314	0.00113	CcSEcCtD
Lercanidipine—Vomiting—Betamethasone—ankylosing spondylitis	0.000312	0.00112	CcSEcCtD
Lercanidipine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000312	0.00112	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00031	0.00112	CcSEcCtD
Lercanidipine—Rash—Dexamethasone—ankylosing spondylitis	0.000309	0.00111	CcSEcCtD
Lercanidipine—Rash—Betamethasone—ankylosing spondylitis	0.000309	0.00111	CcSEcCtD
Lercanidipine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000309	0.00111	CcSEcCtD
Lercanidipine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000309	0.00111	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000308	0.00111	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—ankylosing spondylitis	0.000308	0.00111	CcSEcCtD
Lercanidipine—Headache—Dexamethasone—ankylosing spondylitis	0.000307	0.00111	CcSEcCtD
Lercanidipine—Headache—Betamethasone—ankylosing spondylitis	0.000307	0.00111	CcSEcCtD
Lercanidipine—Asthenia—Prednisone—ankylosing spondylitis	0.000306	0.0011	CcSEcCtD
Lercanidipine—Pruritus—Prednisone—ankylosing spondylitis	0.000302	0.00109	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000294	0.00106	CcSEcCtD
Lercanidipine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000292	0.00105	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000292	0.00105	CcSEcCtD
Lercanidipine—Nausea—Betamethasone—ankylosing spondylitis	0.000291	0.00105	CcSEcCtD
Lercanidipine—Nausea—Dexamethasone—ankylosing spondylitis	0.000291	0.00105	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—ankylosing spondylitis	0.000283	0.00102	CcSEcCtD
Lercanidipine—Dizziness—Prednisone—ankylosing spondylitis	0.000282	0.00102	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000282	0.00102	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000282	0.00102	CcSEcCtD
Lercanidipine—Vomiting—Prednisone—ankylosing spondylitis	0.000271	0.000977	CcSEcCtD
Lercanidipine—Rash—Prednisone—ankylosing spondylitis	0.000269	0.000969	CcSEcCtD
Lercanidipine—Dermatitis—Prednisone—ankylosing spondylitis	0.000269	0.000968	CcSEcCtD
Lercanidipine—Headache—Prednisone—ankylosing spondylitis	0.000267	0.000963	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000263	0.000946	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—ankylosing spondylitis	0.000256	0.000922	CcSEcCtD
Lercanidipine—Nausea—Prednisone—ankylosing spondylitis	0.000254	0.000913	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—ankylosing spondylitis	0.000252	0.000909	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000244	0.000879	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—ankylosing spondylitis	0.000236	0.000849	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—ankylosing spondylitis	0.000227	0.000817	CcSEcCtD
Lercanidipine—Rash—Methotrexate—ankylosing spondylitis	0.000225	0.00081	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000225	0.000809	CcSEcCtD
Lercanidipine—Headache—Methotrexate—ankylosing spondylitis	0.000223	0.000805	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—ankylosing spondylitis	0.000212	0.000763	CcSEcCtD
